Understanding the concepts of normal hematopoiesis and the mechanisms of both disease- and treatment-related cytopenias assists in the proper management of patients and rational uses of hematopoietic growth factors, particularly in those cancer patients receiving chemotherapy with or without stem and progenitor cell transplantation.
Get full access to this article
View all access options for this article.
References
1.
Van ZantG., deHaanG., RichI.N.. Alternatives to stem cell renewal from a development viewpoint.Exp Hematol.1997; 25: 187–192.